MENU
+Compare
RDY
Stock ticker: NYSE
AS OF
Sep 16, 04:59 PM (EDT)
Price
$14.73
Change
+$0.10 (+0.68%)
Capitalization
12.27B

RDY Dr. Reddy's Laboratories Ltd Forecast, Technical & Fundamental Analysis

RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RDY with price predictions
Sep 15, 2025

RDY's Stochastic Oscillator is staying in overbought zone for 3 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RDY broke above its upper Bollinger Band on September 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 09, 2025. You may want to consider a long position or call options on RDY as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RDY just turned positive on August 13, 2025. Looking at past instances where RDY's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

RDY moved above its 50-day moving average on September 09, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RDY crossed bullishly above the 50-day moving average on September 11, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RDY advanced for three days, in of 326 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 265 cases where RDY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RDY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.071) is normal, around the industry mean (17.216). P/E Ratio (18.964) is within average values for comparable stocks, (74.405). Projected Growth (PEG Ratio) (3.254) is also within normal values, averaging (1.893). RDY has a moderately low Dividend Yield (0.006) as compared to the industry average of (0.030). P/S Ratio (3.223) is also within normal values, averaging (46.810).

View a ticker or compare two or three
RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RDY is expected to report earnings to rise 1.90% to 20 cents per share on October 24

Dr. Reddy's Laboratories Ltd RDY Stock Earnings Reports
Q3'25
Est.
$0.20
Q2'25
Missed
by $0.01
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.03
The last earnings report on July 23 showed earnings per share of 20 cents, missing the estimate of 20 cents. With 166.70K shares outstanding, the current market capitalization sits at 12.27B.
A.I.Advisor
published Dividends

RDY paid dividends on August 06, 2025

Dr. Reddy's Laboratories Ltd RDY Stock Dividends
А dividend of $0.09 per share was paid with a record date of August 06, 2025, and an ex-dividend date of July 25, 2025. Read more...
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
8-2-337, Road No. 3
Phone
+91 4049002900
Employees
25863
Web
https://www.drreddys.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PWZ23.950.05
+0.21%
Invesco California AMT-Free Muni Bd ETF
PRIV25.580.02
+0.08%
SPDR SSGA Apollo IG Public & Private Credit ETF
FLSW38.64N/A
N/A
Franklin FTSE Switzerland ETF
USRD32.72N/A
N/A
Themes US R&D Champions ETF
VALQ64.15-0.28
-0.44%
American Century® U.S. Quality Value ETF

RDY and Stocks

Correlation & Price change

A.I.dvisor tells us that RDY and HROW have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDY and HROW's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
-0.20%
HROW - RDY
30%
Poorly correlated
+8.63%
COLL - RDY
29%
Poorly correlated
-6.43%
AVDL - RDY
27%
Poorly correlated
-1.36%
VTRS - RDY
27%
Poorly correlated
-3.61%
OGI - RDY
25%
Poorly correlated
+3.01%
More

Groups containing RDY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
-0.20%
Pharmaceuticals: Generic
industry (221 stocks)
10%
Poorly correlated
+0.20%